1. Home
  2. HKIT vs CLGN Comparison

HKIT vs CLGN Comparison

Compare HKIT & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HKIT

Hitek Global Inc.

N/A

Current Price

$2.42

Market Cap

28.3M

Sector

Technology

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

N/A

Current Price

$3.39

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HKIT
CLGN
Founded
1996
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
5.2M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
HKIT
CLGN
Price
$2.42
$3.39
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
26.0K
9.8M
Earning Date
04-24-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.26
52 Week High
$8.80
$3.91

Technical Indicators

Market Signals
Indicator
HKIT
CLGN
Relative Strength Index (RSI) 39.37 87.30
Support Level $2.36 $0.34
Resistance Level $2.59 $3.91
Average True Range (ATR) 0.19 0.25
MACD -0.06 0.29
Stochastic Oscillator 6.61 86.01

Price Performance

Historical Comparison
HKIT
CLGN

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: